Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0301 per EA under NDC 62756013802. Its NADAC has been published 415 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 2006.
Strength
300 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756013802
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077242FDA Approved
8/24/2006
On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 415 times since Nov 28, 2013, and over the history we have for it it has declined 46.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per EA |
|---|---|
| All-time high | $0.0676 (Feb 12, 2014) |
| All-time low | $0.0301 (Aug 19, 2026) |
| 52-week high | $0.0361 |
| 52-week low | $0.0301 |
| Median price | $0.0422 |
| Average price | $0.0426 |
| Largest weekly change | +18.3% (Aug 24, 2022) |
| Weeks tracked | 415 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.0301 per EA (NDC 62756013802), effective Aug 19, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 46.5%. It has been tracked across 415 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0301 (Aug 19, 2026) to a high of $0.0676 (Feb 12, 2014), with a median of $0.0422 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 62756013802) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.